During the past decade, University of Cincinnati Medical Center conducted 169 clinical trials. In the 10-year time frame, 169 clinical trials started and 94 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 83 clinical trials started and 58 clinical trials were completed. i.e. 69.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Cincinnati Medical Center" #1 sponsor was "University of Cincinnati" with 49 trials, followed by "Pfizer" with 14 trials sponsored, "Lindner Center of HOPE" with 9 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored and "Celgene" with 6 trials sponsored. Other sponsors include 210 different institutions and companies that sponsored additional 165 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cincinnati Medical Center" #1 collaborator was "University of Cincinnati" with 17 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 15 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 14 trials as a collaborator, "AstraZeneca" with 10 trials as a collaborator and "Medical University of South Carolina" with 9 trials as a collaborator. Other collaborators include 168 different institutions and companies that were collaborators in the rest 123 trials.

According to Clinical.Site data, the most researched conditions in "University of Cincinnati Medical Center" are "HIV Infections" (9 trials), "Bipolar Disorder" (7 trials), "Coronary Artery Disease" (7 trials), "Stroke" (7 trials) and "Traumatic Brain Injury" (7 trials). Many other conditions were trialed in "University of Cincinnati Medical Center" in a lesser frequency.

Most popular intervention types in "University of Cincinnati Medical Center" are "Drug" (210 trials), "Other" (36 trials), "Biological" (29 trials), "Device" (26 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (45 trials), "Cisplatin" (8 trials), "Pembrolizumab" (8 trials), "Carboplatin" (4 trials) and "Gemcitabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of Cincinnati Medical Center" are 280 trials for "All" genders, 13 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 88 active trials in "University of Cincinnati Medical Center". 1 are not yet recruiting, 57 are recruiting, 29 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 155 completed trials in University of Cincinnati Medical Center, 1 suspended trials, and 37 terminated clinical trials to date.

Out of the total trials that were conducted in University of Cincinnati Medical Center, 29 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 36 trials, and there were also 35 trials that are defined as “Not Applicable".